Zobrazeno 1 - 10
of 87
pro vyhledávání: '"René-Olivier Casasnovas"'
Autor:
Pierre Sesques, Amy A. Kirkwood, Mi Kwon, Kai Rejeski, Michael D. Jain, Roberta Di Blasi, Gabriel Brisou, François-Xavier Gros, Fabien le Bras, Pierre Bories, Sylvain Choquet, Marie-Thérèse Rubio, Gloria Iacoboni, Maeve O’Reilly, René-Olivier Casasnovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Julie Abraham, Cristina Castilla Llorente, Mickael Loschi, Sylvain Carras, Adrien Chauchet, Laurianne Drieu La Rochelle, Olivier Hermine, Stéphanie Guidez, Pascale Cony-Makhoul, Patrick Fogarty, Steven Le Gouill, Franck Morschhauser, Thomas Gastinne, Guillaume Cartron, Marion Subklewe, Frederick L. Locke, Robin Sanderson, Pere Barba, Roch Houot, Emmanuel Bachy
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-10 (2024)
Abstract Autologous anti-CD19 chimeric antigen receptor (CAR) T cells are now used in routine practice for relapsed/refractory (R/R) large B-cell lymphoma (LBCL). Severe (grade ≥ 3) cytokine release syndrome (CRS) and immune effector cell-associate
Externí odkaz:
https://doaj.org/article/8b4e23a2ec6b43d29b08dcb92f281971
Autor:
Anastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, Pierre Feugier, Monica Tani, Hervé Ghesquières, Gerardo Musuraca, Francesca Gaia Rossi, Francesco Merli, Romain Guièze, Emmanuel Gyan, Guido Gini, Dario Marino, Remy Gressin, Franck Morschhauser, Federica Cavallo, Francesca Palombi, Annarita Conconi, Benoît Tessoulin, Hervé Tilly, Manuela Zanni, Maria Giuseppina Cabras, Enrico Capochiani, Catello Califano, Melania Celli, Alessandro Pulsoni, Francesco Angrilli, Ubaldo Occhini, René-Olivier Casasnovas, Guillaume Cartron, Liliana Devizzi, Corinne Haioun, Anna Marina Liberati, Roch Houot, Michele Merli, Giuseppe Pietrantuono, Francesca Re, Michele Spina, Francesco Landi, Franco Cavalli, Francesco Bertoni, Davide Rossi, Nicoletta Ielmini, Elena Borgo, Stefano Luminari, Emanuele Zucca, Catherine Thieblemont
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The IELSG38 trial was conducted to investigate the effects of subcutaneous (SC) rituximab on the complete remission (CR) rate and the benefits of SC maintenance in patients with extranodal marginal zone lymphoma (MZL) who received frontline treatment
Externí odkaz:
https://doaj.org/article/ca0b0cb56ee341db9e250e5812bdbf1f
Autor:
Eldad J. Dann, René-Olivier Casasnovas
Publikováno v:
Cancers, Vol 16, Iss 11, p 2059 (2024)
The last 3 decades have witnessed a major evolution in the treatment of advanced-stage Hodgkin lymphoma (HL). The most prominent of these developments include the introduction of the international prognostic scoring (IPS) system; therapeutic decision
Externí odkaz:
https://doaj.org/article/d984e4622169496e869ece28d7768e85
Autor:
Simon Le Gallou, Faustine Lhomme, Jonathan M. Irish, Anna Mingam, Celine Pangault, Celine Monvoisin, Juliette Ferrant, Imane Azzaoui, Delphine Rossille, Krimo Bouabdallah, Gandhi Damaj, Guillaume Cartron, Pascal Godmer, Steven Le Gouill, René-Olivier Casasnovas, Thierry Jo Molina, Roch Houot, Thierry Lamy, Karin Tarte, Thierry Fest, Mikael Roussel
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, an
Externí odkaz:
https://doaj.org/article/fb775c7c5eb446dba1369cb01bda5fbe
Autor:
Steeve Chevreux, Sandra de Barros, Camille Laurent, Amandine Durand, Cyrille Delpierre, Philippine Robert, Clémentine Joubert, Samuel Griolet, Salim Kanoun, Jean-Noël Bastie, René-Olivier Casasnovas, Cédric Rossi
Publikováno v:
Cancers, Vol 15, Iss 1, p 53 (2022)
Introduction: Whereas numerous studies on several cancers describe the link between social conditions and disease severity, little is known about the social and demographic characteristics of Hodgkin lymphoma (HL) patients. At diagnosis, 10–15% of
Externí odkaz:
https://doaj.org/article/6ee8c0dc8a1b4b2ba5da0aa927ff995a
Autor:
Raphaël Busson, Marleen van der Kaaij, Nicolas Mounier, Berthe M. P. Aleman, Catherine Thiéblemont, Aspasia Stamatoullas, Vincent Ribrag, Hervé Tilly, Corinne Haioun, René-Olivier Casasnovas, Hanneke C. Kluin-Nelemans, Michel Henry-Amar
Publikováno v:
Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-13 (2019)
Abstract Background Long-term lymphoma survivors often complain of persistent fatigue that remains unexplained. While largely reported in Hodgkin lymphoma (HL), long-term fatigue is poorly documented in non-Hodgkin lymphomas (NHL). Data collected in
Externí odkaz:
https://doaj.org/article/ae5f7853b2e3475eb0340f83e61a3688
Autor:
Cédric Rossi, Marie Tosolini, Pauline Gravelle, Sarah Pericart, Salim Kanoun, Solene Evrard, Julia Gilhodes, Don-Marc Franchini, Nadia Amara, Charlotte Syrykh, Pierre Bories, Lucie Oberic, Loïc Ysebaert, Laurent Martin, Selim Ramla, Philippine Robert, Claire Tabouret-Viaud, René-Olivier Casasnovas, Jean-Jacques Fournié, Christine Bezombes, Camille Laurent
Publikováno v:
Haematologica, Vol 107, Iss 1 (2020)
Follicular lymphoma (FL) is the most common indolent lymphoma. Despite the clear benefit of CD20-based therapy, a subset of FL patients still progress to aggressive lymphoma. Thus, identifying early biomarkers that incorporate positron emission tomog
Externí odkaz:
https://doaj.org/article/17e0b3bb0ef347679114e419485e4a6e
Autor:
Marie-Hélène Delfau-Larue, Axel van der Gucht, Jehan Dupuis, Jean-Philippe Jais, Isabelle Nel, Asma Beldi-Ferchiou, Salma Hamdane, Ichrafe Benmaad, Gaelle Laboure, Benjamin Verret, Corinne Haioun, Christiane Copie-Bergman, Alina Berriolo-Riedinger, Philippine Robert, René-Olivier Casasnovas, Emmanuel Itti
Publikováno v:
Blood Advances, Vol 2, Iss 7, Pp 807-816 (2018)
Abstract: Outcomes for follicular lymphoma (FL) have greatly improved, but most patients will ultimately relapse. High total metabolic tumor volume (TMTV), computed from baseline 18F-fluorodeoxyglucose–positron emission tomography (PET), is associa
Externí odkaz:
https://doaj.org/article/52d5dd863f63494f8e1f47287b4fc546
Autor:
Maxime Jullien, Benoit Tessoulin, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Bruno Villemagne, Rémy Gressin, Kamal Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc-Matthieu Fornecker, Jean-Marc Schiano De Colella, Pierre Feugier, Olivier Hermine, Guillaume Cartron, Christophe Bonnet, Marc André, Clément Bailly, René-Olivier Casasnovas, Steven Le Gouill
Publikováno v:
Cancers, Vol 13, Iss 18, p 4503 (2021)
Background. Muscle depletion (MD) assessed by computed tomography (CT) has been shown to be a predictive marker in solid tumors, but has not been assessed in non-Hodgkin’s lymphomas. Despite software improvements, MD measurement remains highly time
Externí odkaz:
https://doaj.org/article/af796a44b5d04a559cae7ca0e524e15a
Autor:
Nicolas Mounier, Taoufik El Gnaoui, Hervé Tilly, Danièle Canioni, Catherine Sebban, René-Olivier Casasnovas, Richard Delarue, Anne Sonet, Pauline Beaussart, Tony Petrella, Sylvie Castaigne, Serge Bologna, Gilles Salles, Alain Rahmouni, Philippe Gaulard, Corinne Haioun
Publikováno v:
Haematologica, Vol 98, Iss 11 (2013)
A previous pilot study with rituximab, gemcitabine and oxaliplatin showed promising activity in patients with refractory/relapsed B-cell lymphoma. We, therefore, conducted a phase II study to determine whether these results could be reproduced in a m
Externí odkaz:
https://doaj.org/article/054a821271f04e3b922eb8f262a1b18d